Integra LifeSciences (IART) Stock Forecast & Price Target
Score
Integra LifeSciences Holdings Corporation price target
| IART | |
|---|---|
| Low | $13.00 |
| Average | $15.80 |
| High | $25.00 |
| Upside vs current price | +9.7% |
The average target of $15.80 is +9.7% versus the current IART price of $14.40.
Integra LifeSciences Holdings Corporation analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 1 |
| Buy | 2 |
| Hold | 7 |
| Sell | 0 |
| Strong sell | 2 |
| Consensus | Hold |
12 analysts cover IART.
Integra LifeSciences Holdings Corporation EPS and revenue estimates
The estimate table for the Integra LifeSciences Holdings Corporation keeps 2026 EPS $2.34, 2027 EPS $2.39, and years with fewer than three analysts are not filled in.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $2.34 | $1.64B |
| 2027 | $2.39 | $1.67B |
Is Integra LifeSciences Holdings Corporation a buy or sell?
Of the 12 analysts covering Integra LifeSciences Holdings Corporation, 3 rate it a buy (1 strong buy and 2 buy), 7 rate it a hold, and 2 rate it a sell (0 sell and 2 strong sell).
The IART consensus label is Hold, beside 3 buy-side ratings and 2 sell-side ratings.
The average target of $15.80 implies +9.7% versus the current price of $14.40.
the Integra LifeSciences Holdings Corporation closes with 3 buy-side ratings and 2 on the sell side. The headcount is Hold.
Reading the Integra LifeSciences Holdings Corporation forecast
Analysts are far apart on IART. The published low is $13.00, the average is $15.80, and the high is $25.00.
From today's $14.40 print, the IART average target is +9.7% away.
IART coverage does not pile into one bucket: 3 of 12 analysts are on the buy side, 7 are at hold, and 2 are on the sell side, and the published consensus is Hold.
IART targets have eased: $13.50 in the last month against $13.80 over the last quarter.
IART coverage is thin at 12 analysts, and one revision moves the average.
Integra LifeSciences Holdings Corporation forecast questions
What is the IART price target?
The published range for IART is $13.00 to $25.00, with an average of $15.80. That average is +9.7% versus the current price of $14.40.
Is Integra LifeSciences Holdings Corporation a buy or sell?
Of the 12 analysts covering Integra LifeSciences Holdings Corporation, 3 rate it a buy, 7 rate it a hold, and 2 rate it a sell. The consensus is Hold, which for IART is 3 on the buy side, 7 at hold, and 2 on the sell side.
What is the EPS estimate for Integra LifeSciences Holdings Corporation?
Analyst EPS estimates for Integra LifeSciences Holdings Corporation: 2026 $2.34, 2027 $2.39.
What is the revenue estimate for Integra LifeSciences Holdings Corporation?
Analyst revenue estimates for Integra LifeSciences Holdings Corporation: 2026 $1.64B, 2027 $1.67B.
How many analysts cover IART?
12 analysts cover IART. Their consensus on IART is Hold, across those 12.